Skip to main content
. 2017 Jun 7;34(9):1784–1795. doi: 10.1007/s11095-017-2183-6

Fig. 2.

Fig. 2

Visual predictive checks for the final pharmacokinetic model of erenumab concentrations. Colored symbols and lines are individual observations and the medians of the observations for the corresponding dosing cohorts; solid black lines and shaded bands are the model predicted 50th and 90th percentiles. IV, intravenous; Q4W, every 4 weeks; SC, subcutaneous.